Nexstim

Nexstim is a globally operating medical technology company committed to improving the lives of patients facing significant clinical challenges. Specializing in personalized and effective therapies and diagnostics for brain diseases and disorders, Nexstim has established itself as a leader in the medical field.

At the heart of Nexstim's innovation is the SmartFocus® technology, a world-leading non-invasive brain stimulation method. This navigated transcranial magnetic stimulation (nTMS) technology offers unparalleled 3D navigation, ensuring precise and personalized targeting of TMS to specific brain areas. Nexstim's proprietary Navigated Brain Therapy (NBT®) system, powered by SmartFocus®, is FDA-cleared for treating major depressive disorder (MDD) in the United States and CE marked in Europe for major depression and chronic neuropathic pain. The primary address of Nexstim is Elimäenkatu 9 B, Helsinki, FI-00510, FI.

Furthermore, Nexstim commercializes its SmartFocus®-based Navigated Brain Stimulation (NBS) system for diagnostic purposes. The NBS system stands as the only FDA-cleared and CE-marked navigated TMS system for pre-surgical mapping of speech and motor cortices. Nexstim continues to advance medical technology, providing innovative solutions and improving patient outcomes worldwide. We invite the manager of Nexstim to create a customized and exclusive company showcase and product listing on our platform.